Association between serum vitamin D status and severity of liver cirrhosis: implications for therapeutic targeting in Nigerian patients
- PMID: 39135191
- PMCID: PMC11318153
- DOI: 10.1186/s12876-024-03353-1
Association between serum vitamin D status and severity of liver cirrhosis: implications for therapeutic targeting in Nigerian patients
Abstract
Background: Liver cirrhosis is a chronic and progressive liver disease with significant global health implications. Recent evidence suggests an association between serum vitamin D levels and the severity of liver cirrhosis, potentially serving as a therapeutic target. This study aimed to investigate the relationship between serum vitamin D status and the severity of liver cirrhosis in a population of Nigerian patients.
Methods: This analytical, cross-sectional study involved 201 participants, including 103 with liver cirrhosis and 98 age- and sex-matched controls. Serum vitamin D was measured using ELISA, with deficiency defined as < 20 ng/ml. Cirrhosis severity was assessed using Child-Pugh and MELD scores. Spearman's correlation was used to assess the relationship between vitamin D and severity of liver cirrhosis while ordinal regression analysis assessed its performance as an indicator of the disease severity.
Result: Among cirrhotic patients, 36.9% were deficient, 31.1% insufficient, and 32.0% had sufficient vitamin D levels. Serum vitamin D showed strong negative correlations with Child-Pugh and MELD scores (r = -0.696, p < 0.001; r = -0.734, p < 0.001, respectively). Ordinal regression showed that higher vitamin D levels were associated with lower severity scores (Child-Pugh: OR = 0.856, 95% CI: 0.815-0.900, p < 0.001; MELD: OR = 0.875, 95% CI: 0.837-0.915, p < 0.001).
Conclusion: Lower serum vitamin D levels correlated with increased liver cirrhosis severity, suggesting its potential as both a prognostic marker and therapeutic target. Further studies should investigate the efficacy of vitamin D supplementation in improving cirrhosis outcomes.
Keywords: Liver cirrhosis; Nigerian; Severity; Therapeutic targeting; Vitamin D.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Hepatic Decompensation in Patients with Chronic Liver Disease: Exploring the Role of Vitamin D Deficiency as a Prognostic Marker.J Assoc Physicians India. 2024 Mar;72(3):82-86. doi: 10.59556/japi.72.0352. J Assoc Physicians India. 2024. PMID: 38736123
-
Association of low serum 25-Hydroxy vitamin D [25(OH) d] with hepatic encephalopathy in patients with decompensated liver cirrhosis.Arab J Gastroenterol. 2024 May;25(2):182-187. doi: 10.1016/j.ajg.2024.01.014. Epub 2024 Mar 8. Arab J Gastroenterol. 2024. PMID: 38458876
-
Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.Wien Klin Wochenschr. 2017 Jan;129(1-2):8-15. doi: 10.1007/s00508-016-1127-1. Epub 2016 Nov 25. Wien Klin Wochenschr. 2017. PMID: 27888359 Free PMC article.
-
Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis.J Zhejiang Univ Sci B. 2014 Oct;15(10):900-6. doi: 10.1631/jzus.B1400073. J Zhejiang Univ Sci B. 2014. PMID: 25294379 Free PMC article. Review.
-
The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis.Int J Chron Obstruct Pulmon Dis. 2016 Oct 19;11:2597-2607. doi: 10.2147/COPD.S101382. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27799758 Free PMC article. Review.
References
-
- Adekanle O, Ijarotimi O, obasi O, Anthony-Nwojo GNNDA. A Southwest Nigerian tertiary hospital 5-year study of the pattern of liver disease admission. Niger J Gastroenterol Hepatol. 2020;12:18–23.10.4103/NJGH.NJGH_7_20 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical